Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2017-06-01
2018-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The deficiency is the result of mutations of the respective clotting factor genes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patterns of Hemophilia Care in Assiut Children Patients
NCT05980377
A Study of Factor Inhibitors in Adult Patients With Hemophilia and Von Willebrand's Disease in Upper Egypt
NCT04106323
Musculoskeletal Function in Hemophilia
NCT00324493
Platelet Function in Patients With Hemophilia A
NCT02093065
Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A
NCT06020456
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
According to the World Federation of Hemophilia, 400 000 people worldwide \& 5,307 people in Egypt are suffering from hemophilia.
Hemophilia A is more common than hemophilia B, representing 80-85 % of the total hemophilia population.
Signs and symptoms of hemophilia vary according to the level of clotting factors, mild, moderate and sever.
* Unexplained excessive bleeding from cuts or injuries
* Epistaxis without a known cause
* Many large or deep bruises
* Hamoarthritis
* Hematuria and Melena.
* Intracranial hemorrhage and death
* In infants, unexplained irritability
it is subjective representation of health, including not only physical,mental and social, but also emotional and everyday life dimensions in terms of well-being. Several definitions of QoL have been provided, the definition of the WHO viewing QoL as 'individuals perceptions of their position in life in the context of culture and value systems in which they live and in relation to their goals, expectation standards and concerns'
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Different age groups (pediatric - adolescence - adult )
* Home or hospitalized treatment
* complications such as joint swelling , spontaneous bleeding, etc….
Exclusion Criteria
2- Diseases that affect joints such as osteoarthritis, SLE , etc.. 3- Mentally retarded patients.
10 Years
70 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
peter khalil
assiut
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assuit University
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Assiut1987
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.